针对2型糖尿病和其并发症的天然产品
Farshad Niazpour1, Reza Meshkani1
1Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Phytotherapy research : PTR
|August 27, 2025
概括
在治疗2型糖尿病 (T2DM) 和其并发症方面,天然产品通过抑制铁症具有前景. 这些化合物保护细胞损伤和氧化应激, 提供潜在的治疗策略.
科学领域:
- 生物医学
- 细胞生物学
- 药理学
背景情况:
- 二型糖尿病及其并发症对全球健康构成重大挑战.
- 铁死是一种明显的细胞死亡途径,越来越多地与T2DM的发病有关,特别是在β细胞功能障碍和胰岛素抵抗方面.
研究的目的:
- 审查当前关于抑制铁和缓解T2DM及其并发症的天然产品的证据.
- 探索天然产品在T2DM中具有保护作用的机制.
主要方法:
- 在T2DM中研究天然产品和铁症的临床前研究文献综述.
- 通过自然产品调节的信号通路和分子点的分析.
主要成果:
- 自然产品增强抗氧化防御,通常通过NRF2激活,调节HMOX1和GPX4以抵消铁死的特征.
- 化合物在各种糖尿病并发症 (脏病,视网膜病,心血管疾病等) 中表现出有效性. 通过调节关键路径.
- 机制包括抑制铁,减轻组织损伤,调节铁代谢,维护线粒体完整性.
结论:
- 针对铁的天然产品为T2DM及其并发症提供了有前途的治疗途径.
- 进一步的临床研究对于验证临床前发现,阐明机制以及评估人体试验中的安全性和有效性至关重要.
相关概念视频
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K


